Crossmark

Duloxetine versus ‘active’ placebo, placebo or no intervention for major depressive disorder; a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis

Crossref DOI link: https://doi.org/10.1186/s13643-021-01722-5

Published Online: 2021-06-09

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Siddiqui, Faiza

Barbateskovic, Marija

Juul, Sophie

Katakam, Kiran Kumar

Munkholm, Klaus

Gluud, Christian

Jakobsen, Janus Christian
License Information

Text and Data Mining valid from 2021-06-09

Version of Record valid from 2021-06-09
More Information

Article History

Received: 14 September 2020

Accepted: 28 May 2021

First Online: 9 June 2021

Declarations

:

: Not applicable.

: Not applicable.

: All authors except Klaus Munkholm are affiliated with The Copenhagen Trial Unit, which sponsors the systematic review. Klaus Munkholm is affiliated with University of Southern Denmark and Cochrane Denmark. The authors declare that they have no competing interests. JCJ has access to all the data and takes responsibility for the integrity of the data and accuracy of the data analysis.

Document is current

Any future updates will be listed below